Skip to Content

← See all Ranitidine brands

Ranitidine by Apotex Corp.

Dosage form: tablet, film coated
Ingredients: Ranitidine Hydrochloride 150mg
Labeler: Apotex Corp.
NDC Code: 60505-2880

Drug Facts

Active ingredient (in each tablet)

Ranitidine 150 mg (as ranitidine hydrochloride, USP 168 mg)

                                 

Purpose

Acid reducer

Uses

  • relieves heartburn associated with acid indigestion and sour stomach
  • prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages

Warnings

Allergy alert: Do not use if you are allergic to ranitidine or other acid reducers.

Do not use

  • if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor.
  • with other acid reducers
  • if you have kidney disease, except under the advice supervision of a doctor

Ask a doctor before use if you have

  • had heartburn over 3 months. This may be a sign of a more serious condition.
  • heartburn with lightheadedness, sweating or dizziness 
  • chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness
  • frequent chest pain
  • frequent wheezing, particularly with heartburn
  • unexplained weight loss
  • nausea or vomiting
  • stomach pain

Stop use and ask a doctor if

  • your heartburn continues or worsens
  • you need to take this product for more than 14 days

If pregnant or breast-feeding, ask a healthcare professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away

Directions

  • adults and children 12 years and over:
    • to relieve symptoms, swallow 1 tablet with a glass of water
    • to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburn
    • can be used up to twice daily (do not take more than 2 tablets in 24 hours)
  • children under 12 years; ask a doctor

Other information

  • do not use if printed foil under bottle cap is broken or torn
  • store at 20°C to 25°C (68°F to 77°F)
  • avoid excessive heat or humidity
  • this product is sodium and sugar free

Inactive ingredients

carnauba wax, colloidal silicon dioxide, ferric oxide red, ferric oxide yellow, hypromellose, magnesium stearate, microcrystalline cellulose, polydextrose, titanium dioxide and vanillin

Questions?

Call 1-800-706-5575 (Monday to Friday 8:30 a.m. – 5:00 p.m. Eastern Standard Time) 

Principal Display Panel

Maximum Strength

Ranitidine Tablets USP, 150 mg - Bottle Label - 10,000 Tablets

Acid Reducer

Prevents & Relieves Heartburn

Associated with Acid Indigestion & Sour Stomach

Distributed by: Apotex Corp. Weston, Florida 33326, USA

RANITIDINE 
ranitidine hydrochloride tablet, film coated
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:60505-2880
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Ranitidine Hydrochloride (ranitidine) ranitidine150 mg
Inactive Ingredients
Ingredient NameStrength
Carnauba Wax 
Silicon Dioxide 
Hypromelloses 
Magnesium Stearate 
Cellulose, Microcrystalline 
Polydextrose 
Titanium Dioxide 
Vanillin 
Ferric Oxide Red 
Ferric Oxide Yellow 
Product Characteristics
ColorPINKScoreno score
ShapeROUNDSize9mm
FlavorImprint CodeAPO;RAN;150
Contains    
Packaging
#Item CodePackage Description
1NDC:60505-2880-710000 TABLET, FILM COATED in 1 BOTTLE
2NDC:60505-2880-03 BLISTER PACK in 1 CARTON
28 TABLET, FILM COATED in 1 BLISTER PACK
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA20017207/15/2013
Labeler - Apotex Corp. (845263701)
Registrant - Apotex Inc. (209429182)
Establishment
NameAddressID/FEIOperations
Apotex Inc209429182manufacture(60505-2880), analysis(60505-2880)

 
Apotex Corp.

← See all Ranitidine brands

Medically reviewed on Dec 1, 2017

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide